Table 3.

Clinical and laboratory characteristics and outcome in COVID-19 with TTS of case series

Variables	Values in median/n (% or IQR)
Age, years	57 (39–65)
Male n (%)	5 (100%)
Clinical features
Dyspnea n (%)	4 (80%)
Chest Pain n (%)	1 (20%)
Cardiac and inflammatory markers
Troponin I (ng/mL)	11.4 (0.55–12.55)
D-dimer (microgram/mL)	1.8 (1.3–11.5)
CRP (mg/dL)	207 (162–277)
CK-MB (ng/mL)	26.9 (23.9–101.6)
ECG and echocardiographic finding
Wall motion abnormalities n (%)	5(100%)
Right ventricular dysfunction n (%)	1 (20%)
Pericardial effusion	1 (20%)
ST Segment elevation n (%)	2 (40%)
T wave inversion n (%)	1 (20%)
Sinus tachycardia n (%)	1 (20%)
In-hospital complication
ARDS n (%)	4 (80%)
AKI n (%)	4 (80%)
Outcome
Recovered and Discharged n (%)	2 (40%)
Hospitalized n (%)	1 (20%)
Death n (%)	2 (40%)

IQR interquartile range, ECG electrocardiography, ARDS acute respiratory destress syndrome, AKI acute kidney injury, CRP C-reactive protein, CK-MB creatine-kinase MB